Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01293136 · ClinicalTrials.gov registry record
Retrospective Femoral Nerve Block Study
A clinical trial of Other Reconstructive Surgery, sponsored by Nationwide Children's Hospital.
- Completed
- Registry status
- 400
- Enrollment target
- 1
- Study location
NCT01293136 is a study of Other Reconstructive Surgery that has completed, run by Nationwide Children's Hospital. The registered enrollment target is 400 participants. The trial reports 1 study location across 1 state.
The verdict
NCT01293136, a study of Other Reconstructive Surgery, has completed, sponsored by Nationwide Children's Hospital.
- COMPLETED
- Registry status
- 400 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a retrospective review to evaluate the efficacy of femoral nerve block in providing analgesia following reconstructive surgery of the knee and to compare the postoperative course of patients who received femoral nerve block with a retrospective cohort who were cared for prior to the institution of a regional anesthesia program. The investigators hypothesize that femoral nerve blockade limits postoperative opioid needs, improves analgesia and facilitates discharge home when compared to intravenous opioid use following reconstructive knee surgery.
Conditions Studied
Interventions
- PROCEDURE Femoral nerve block
- DRUG Intravenous opioids
Study Locations (1)
Ohio
- Nationwide Children's Hospital - Columbus
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 400 participants |
| Start Date | 2011-02 |
| Est. Completion | 2011-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01293136
The ClinicalTrials.gov registry entry for NCT01293136 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 400 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Nationwide Children's Hospital, which has 188 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Other Reconstructive Surgery appearing as the primary indexed condition, and to 2 interventions - of which Femoral nerve block is the first listed.
NCT01293136 reports 1 study location spanning 1 distinct geographic area - top geographies include Ohio.
Frequently Asked Questions
What is clinical trial NCT01293136 about?
NCT01293136 is a clinical study titled "Retrospective Femoral Nerve Block Study". This is a retrospective review to evaluate the efficacy of femoral nerve block in providing analgesia following reconstructive surgery of the knee and to compare the postoperative course of patients who received femoral nerve block with a retrospective cohort who were cared for prior to the institut...
What is the current status of trial NCT01293136?
This trial is currently completed. The enrollment target is 400 participants. The study started on 2011-02. Estimated completion is 2011-12.
What conditions does trial NCT01293136 study?
This clinical trial studies the following conditions: Other Reconstructive Surgery.
What interventions are being tested in trial NCT01293136?
The interventions under investigation include: Femoral nerve block (PROCEDURE), Intravenous opioids (DRUG).
Who is sponsoring clinical trial NCT01293136?
This trial is sponsored by Nationwide Children's Hospital, which has 188 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01293136 being conducted?
This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.